Foresite Capital Management Iv, LLC Olema Pharmaceuticals, Inc. Transaction History

Foresite Capital Management Iv, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$8.75 - $30.71 $2.99 Million - $10.5 Million	-342,030 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$21.15 - $36.14 $1.08 Million - $1.84 Million	-51,000 Reduced 12.98%	342,030 $9.57 Million
Q1 2021 May 17, 2021	SELL	$27.81 - $53.64 $11.8 Million - $22.8 Million	-425,000 Reduced 51.95%	393,030 $13 Million
Q4 2020 Feb 16, 2021	BUY	$37.09 - $54.5 $30.3 Million - $44.6 Million	818,030 New	818,030 $39.3 Million

129

57.8M

57.5K

34K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $470M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.